Author Archive: Michael Foster

For some folks, it’s almost a reflex to buy gold when inflation hits or volatility ramps up. In times like those, they simply flock to the yellow metal—no questions asked.

But buying gold as a safe haven is a terrible idea, for one simple reason: it doesn’t work.

The dumpster fire year we’re living through now provides an excellent example of gold’s ineffectiveness as an inflation hedge: while inflation soared (it sits at 8.3% as of August), gold has gone the other way, plunging 6.4% since January 1.

That lousy performance isn’t just a one-off. Gold has actually fallen 7% in the last decade.… Read more

Plenty of folks are starting to look toward the new year, and I’m getting a lot of questions about my outlook for high-yield closed-end funds (CEFs) for the rest of ’22 and into ’23.

Of course, no one has a crystal ball when it comes to CEFs, stocks or the economy in the short run, but my take is that we’ll likely see continued volatility in the back end of 2022, with better conditions in 2023, as the so-called “terminal rate” of the Fed’s hiking cycle comes into view.

Luckily, there are CEFs out there called covered-call funds that are purpose-built for this environment, handing us safe 7%+ dividends that actually get stronger when volatility picks up.… Read more

The US consumer just got a $162-billion “pay raise,” and I’m betting you haven’t heard a word about it. Today, we’re going to tap that “extra” cash through a 6.6%-yielding fund that trades at 87 cents on the dollar.

What I’m getting at is the good news story we’ve heard little about in the media: the extra cash consumers are pocketing thanks to the recent plunge in gasoline prices.

It’s no small amount, either: according to Mark Zandi, chief economist at Moody’s Analytics, US households save about $125 billion in total for every dollar the price at the pump drops. And with average pump prices now around $3.70 a gallon, down from north of $5 in June, we’re looking at about $162 billion being thrown back into the economy, or around $13 billion a month. … Read more

Today we’re in a situation that looks a lot like 2016. And back then, some savvy contrarians tapped it to grab quick 62%+ returns. The same setup is back again—and so is our chance for more upside, plus yields north of 10%.

There are two closed-end funds (CEFs) poised to deliver those high yields (and overall returns); we’ll compare two popular options in a moment. First, let’s delve into the state of the corporate-bond market, because there are a lot of misconceptions floating around right now.

“Junk” Bonds Not as Risky as They Seem

You might know high-yield bonds by their nickname: junk bonds.… Read more

Municipal bonds are too often ignored by investors. Which is a huge missed dividend opportunity.

It’s too bad, because billionaires have been using “munis” to anchor their portfolios for years. And with good reason: as we’ll see in a second, munis can perform well when rates rise. They also pay a high “hidden” yield that beats anything you’d get on a Treasury—and most stocks.

“Munis” Offer Safe, High—and Tax-Free—Yields

I say munis’ yields are “hidden” because they’re tax-free. If you’re in a high tax bracket, I probably don’t have to tell you how valuable a tax-free yield is, but the numbers here are very compelling.… Read more

Some major—and almost totally ignored—news from Washington, D.C., is about to upend the biotech world, turning America into “the world’s pharmacy” in short order—and giving us a chance to buy a solid 6.8% dividend for just 91 cents on the dollar.

That might sound hard to believe for woebegone biotechs, which have fallen further than the S&P 500 this year, going by the performance of the benchmark iShares Biotechnology ETF (IBB). That’s despite the sector’s importance during the pandemic—and despite the fact that some 10,000 Americans turn 65 every day, sharply increasing demand for pharmaceuticals as the senior cohort grows.

Biotech Catches a Cold

The problem is that despite these tailwinds, biotech is weighed down by the same problems that are dragging on the rest of the economy: lower R&D funding as interest rates rise, and supply-chain issues that are hurting productivity.… Read more

Most folks don’t know it, but real estate has clobbered stocks in the long run, and it’s poised to pull off a win again in 2023.

And we dividend investors are nicely lined up to cash in, thanks to a fund throwing off a blockbuster 9.9% yield that’s the perfect play here. I’ll drop the name and ticker in a sec.

First, you read that right: real estate does outperform stocks over the long haul—and by no small amount, either! It’s clear as can be in this comparison between the SPDR Dow Jones REIT ETF (RWR), the index fund for publicly traded real estate investment trusts (REITs), and the S&P 500 over the last 20 years.… Read more

By now you’ve likely heard that September is the worst month for stocks. It’s all over the media! But September is also a great time to buy a unique type of dividend fund that cashes in when volatility rears up (these funds will pay you blockbuster yields north of 7%, too!).

I’m talking about a special type of closed-end fund (CEF) called a covered-call fund, which makes more money every time the market panics. They then turn that cash over to us in the form of a dividend that crushes anything you’d get on a blue-chip stock or Treasury.

Don’t let the jargon-y name throw you.… Read more

Whether you own a Treasury or the typical dividend stock these days, you’re still losing money after inflation.

I know what you’re thinking: tell me something I don’t know!

But there’s a solution hiding in plain sight: closed-end funds (CEFs), a widely overlooked (and publicly traded) asset class that often throws off rich payouts of 8% or more. We’ll do a deep dive into these scandalously overlooked income plays, and how they pay those big (and often monthly) dividends in a moment.

Here’s the top-line takeaway, though: by going with a CEF, you won’t have to sell the blue chips you own now.… Read more

One of the market’s smartest contrarian players just made a shocking move—and we dividend investors need to pay attention.

The contrarian in question? PIMCO, the company that revolutionized the humble closed-end fund (CEF). If you’re reading this, you’ve likely at least heard of CEFs, which are renowned for big dividend payouts: safe 7%+ yields are the hallmark of these (too) often-overlooked investment vehicles.

If you’ve never heard of PIMCO, all you need to know is that the company is to CEFs what Apple (AAPL) is to tech.

And PIMCO’s latest move is yet another signal that now is a great time to boost our positions in the 18 buy-rated funds in the CEF Insider portfolio.… Read more